Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,915,404
  • Shares Outstanding, K 267,560
  • Annual Sales, $ 12,093 M
  • Annual Income, $ 1,100 M
  • 36-Month Beta 1.11
  • Price/Sales 4.18
  • Price/Cash Flow 16.91
  • Price/Book 2.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.92
  • Number of Estimates 12
  • High Estimate 2.98
  • Low Estimate 2.89
  • Prior Year 2.40
  • Growth Rate Est. (year over year) +21.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
237.09 +0.51%
on 10/11/18
265.87 -10.37%
on 10/01/18
-22.32 (-8.56%)
since 09/14/18
3-Month
237.09 +0.51%
on 10/11/18
265.87 -10.37%
on 10/01/18
-8.79 (-3.56%)
since 07/13/18
52-Week
200.08 +19.11%
on 10/17/17
265.87 -10.37%
on 10/01/18
+36.88 (+18.31%)
since 10/13/17

Most Recent Stories

More News
US Diabetes Market Gaining Momentum: 3 Stocks in Focus

A rising geriatric population and lifestyle disorders are expanding the U.S. diabetic population.

FIT : 4.84 (+4.76%)
ABT : 68.70 (-0.91%)
TNDM : 36.27 (+0.39%)
BDX : 238.31 (-1.78%)
MDT : 93.82 (-0.92%)
DXCM : 125.17 (-1.50%)
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2018 earnings conference call on Tuesday, November 6,...

BDX : 238.31 (-1.78%)
BD Breaks Ground at I.D.E.A. Tempe Campus

Officials from BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, were joined today by Gov. Doug Ducey, Tempe Mayor Mark Mitchell and representatives of The Boyer...

BDX : 238.31 (-1.78%)
Tom Polen Promoted to Chief Operating Officer of BD

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to...

BDX : 238.31 (-1.78%)
Global Transplant Diagnostics Markets (2018-2023) Featuring Becton, Dickinson & Co, Bio-Rad Labs, bioMerieux, Merck, Qiagen, F Hoffman-La Roche; and many more - ResearchAndMarkets.com

The "Transplant Diagnostics Market by Technology, Product, Application, Type, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

BDX : 238.31 (-1.78%)
MRK : 69.46 (-0.50%)
Shares of Angiodynamics In Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (ANGO , BDX , BSX , MDT , ABT )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

BSX : 36.43 (-1.51%)
BDX : 238.31 (-1.78%)
ANGO : 20.25 (+0.50%)
Becton Dickinson Set to Possibly Pullback After Yesterday's Rally of 1.69%

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $262.00 to a high of $265.87. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of...

BDX : 238.31 (-1.78%)
Look for Shares of Becton Dickinson to Potentially Pullback after Yesterday's 1.69% Rise

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $262.00 to a high of $265.87. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of...

BDX : 238.31 (-1.78%)
Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

ATHN : 124.63 (-1.56%)
BDX : 238.31 (-1.78%)
VEEV : 90.33 (-1.34%)
ISRG : 519.29 (-2.39%)
The Zacks Analyst Blog Highlights: Becton, Occidental, Phillips, Allstate and Deutsche

The Zacks Analyst Blog Highlights: Becton, Occidental, Phillips, Allstate and Deutsche

ALL : 92.79 (-0.40%)
OXY : 72.24 (-6.13%)
PSX : 107.21 (-2.06%)
BDX : 238.31 (-1.78%)
DB : 11.03 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade BDX with:

Business Summary

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories....

See More

Key Turning Points

2nd Resistance Point 244.36
1st Resistance Point 241.34
Last Price 238.31
1st Support Level 236.80
2nd Support Level 235.28

See More

52-Week High 265.87
Fibonacci 61.8% 240.74
Last Price 238.31
Fibonacci 50% 232.98
Fibonacci 38.2% 225.21
52-Week Low 200.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar